Related Experiment Video
Updated: May 17, 2026

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Epigenetic distortion to VDR transcriptional regulation in prostate cancer cells
Prashant K Singh1, Craig L Doig, Vineet K Dhiman
1Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Abstract:
The current study aimed to examine the gene specific mechanisms by which the actions of the vitamin D receptor (VDR) are distorted in prostate cancer. Transcriptional responses toward the VDR ligand, 1α,25(OH)2D3, were examined in non-malignant prostate epithelial cells (RWPE-1) and compared to the 1α,25(OH)2D3-recalcitrant prostate cancer cells (PC-3). Time resolved transcriptional studies for two VDR target genes revealed selective attenuation and repression of VDR transcriptional responses in PC-3 cells. For example, responses in PC-3 cells revealed suppressed responsiveness of IGFBP3 and G0S2. Furthermore, Chromatin Immunoprecipitation (ChIP) assays revealed that suppressed transcriptional responses in PC-3 cells of IGFBP3 and G0S2 were associated with selective VDR-induced NCOR1 enrichment at VDR-binding regions on target-gene promoter regions. We propose that VDR inappropriately recruits co-repressors in prostate cancer cells. Subsequent direct and indirect mechanisms may induce local DNA methylation and stable transcriptional silencing. Thus a transient epigenetic process mediated by co-repressor binding, namely, the control of H3K9 acetylation, is distorted to favor a more stable epigenetic event, namely DNA methylation. This article is part of a Special Issue entitled 'Vitamin D Workshop'.
Insights
Prostate cancer cells distort vitamin D receptor (VDR) actions by recruiting co-repressors, leading to gene silencing. This epigenetic shift from transient acetylation to stable DNA methylation impacts VDR target genes.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Research
Background:
- The vitamin D receptor (VDR) plays a role in various cellular processes, and its function is often altered in cancer.
- Understanding VDR's specific mechanisms in prostate cancer is crucial for therapeutic development.
Purpose of the Study:
- To investigate the gene-specific mechanisms underlying VDR dysfunction in prostate cancer.
- To compare VDR transcriptional responses in non-malignant versus cancer prostate cells.
Main Methods:
- Time-resolved transcriptional studies of VDR target genes (IGFBP3, G0S2).
- Chromatin Immunoprecipitation (ChIP) assays to analyze VDR and co-repressor binding.
- Comparison of VDR ligand responses in RWPE-1 and PC-3 cell lines.
Main Results:
- Prostate cancer cells (PC-3) exhibit suppressed VDR transcriptional responses compared to normal cells (RWPE-1).
- VDR target genes IGFBP3 and G0S2 showed reduced responsiveness in PC-3 cells.
- VDR-induced enrichment of NCOR1 at target gene promoter regions was observed in PC-3 cells, indicating co-repressor recruitment.
Conclusions:
- VDR inappropriately recruits co-repressors in prostate cancer cells, leading to gene silencing.
- This process involves a shift from transient epigenetic modifications (H3K9 acetylation) to stable DNA methylation.
- Distorted VDR signaling contributes to prostate cancer progression through epigenetic alterations.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Abnormal Proliferation
Cell Specific Gene Expression
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Ras Gene
Ras is a superfamily...

